Terms: = Lung cancer AND FANCC, ENSG00000158169, 2176, RP11-80I15_2, FAC, FA3, FACC, FLJ14675 AND Treatment
43156 results:
1. The Experience of cancer-Related Cognitive Impairment Across Common cancers: Protocol for a Qualitative Systematic Review.
Ibrar M; Rai HK; Main A; McCartney H; Maguire R; Rodriguez MAP
JMIR Res Protoc; 2024 May; 13():e56888. PubMed ID: 38820581
[TBL] [Abstract] [Full Text] [Related]
2. Effect of body mass index and cholesterol-rich apolipoprotein-B-containing lipoproteins on clinical outcome in NSCLC patients treated with immune checkpoint inhibitors-based therapy: A retrospective analysis.
Hu Z; Zheng Y; Zheng J; Wang Y; Liao J; Liu Z; Li J; Cui H
Cancer Med; 2024 Jun; 13(11):e7241. PubMed ID: 38819098
[TBL] [Abstract] [Full Text] [Related]
3. BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity.
Bao Y; Pan Z; Zhao L; Qiu J; Cheng J; Liu L; Qian D
J Transl Med; 2024 May; 22(1):519. PubMed ID: 38816831
[TBL] [Abstract] [Full Text] [Related]
4. The incidence of and risk factors for radiation pneumonitis in patients treated with simultaneous bevacizumab and thoracic radiotherapy.
Chen F; Niu J; Wang M; Zhu H; Guo Z
Radiat Oncol; 2024 May; 19(1):67. PubMed ID: 38816745
[TBL] [Abstract] [Full Text] [Related]
5. CILP2 is a potential biomarker for the prediction and therapeutic target of peritoneal metastases in colorectal cancer.
Ha YJ; Park SH; Tak KH; Lee JL; Kim CW; Kim JH; Kim SY; Kim SK; Yoon YS
Sci Rep; 2024 May; 14(1):12487. PubMed ID: 38816545
[TBL] [Abstract] [Full Text] [Related]
6. Targeting nerve growth factor-mediated osteosarcoma metastasis: mechanistic insights and therapeutic opportunities using larotrectinib.
Hou CH; Chen WL; Lin CY
Cell Death Dis; 2024 May; 15(5):381. PubMed ID: 38816365
[TBL] [Abstract] [Full Text] [Related]
7. Juglone triggers apoptosis of non-small cell lung cancer through the reactive oxygen species -mediated PI3K/Akt pathway.
Zhong J; Hua Y; Zou S; Wang B
PLoS One; 2024; 19(5):e0299921. PubMed ID: 38814975
[TBL] [Abstract] [Full Text] [Related]
8. The effect of care interruptions on mortality in adults resuming antiretroviral therapy.
Moolla H; Davies MA; Davies C; Euvrard J; Prozesky HW; Fox MP; Orrell C; Von Groote P; Johnson LF;
AIDS; 2024 Jul; 38(8):1198-1205. PubMed ID: 38814712
[TBL] [Abstract] [Full Text] [Related]
9. Management and prognosis of patients with cancer of unknown primary: 20 years of experience.
Bardakçi M; Algin E; Düğeroğlu B; Bal Ö; Köş FT; Uncu D
Turk J Med Sci; 2023; 53(6):1722-1731. PubMed ID: 38813492
[TBL] [Abstract] [Full Text] [Related]
10. [Betulinic acid inhibits non-small cell lung cancer by repolarizing tumor-associated macrophages via mTOR signaling pathway].
Zeng AQ; Chen X; Dai Y; Zhao JN
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2376-2384. PubMed ID: 38812138
[TBL] [Abstract] [Full Text] [Related]
11. Trends in cancer mortality among the elderly in China, 2005-2035.
Wang M; Su X; Hu Y; Yang J
PLoS One; 2024; 19(5):e0302903. PubMed ID: 38809949
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy of first-line dual oral pyrotinib plus capetabine therapy in HER2-positive metastatic breast cancer: A real-world retrospective study.
Dai S; Zhang Y; Tan X; Luo F; Yan X
Cancer Med; 2024 Jun; 13(11):e7256. PubMed ID: 38808952
[TBL] [Abstract] [Full Text] [Related]
13. Two new and effective food-extracted immunomodulatory agents exhibit anti-inflammatory response activity in the hACE2 acute lung injury murine model of COVID-19.
Liu S; Wang B; Chen T; Wang H; Liu J; Zhao X; Zhang Y
Front Immunol; 2024; 15():1374541. PubMed ID: 38807598
[TBL] [Abstract] [Full Text] [Related]
14. Immune cell populations in the tumour environment following calcium electropora-tion for cutaneous metastasis: a histopathological study.
Vissing M; Sinius Pouplier S; Munch Larsen L; Krog Frandsen S; Lodin A; Lænkholm AV; Gehl J
Acta Oncol; 2024 May; 63():398-410. PubMed ID: 38804839
[TBL] [Abstract] [Full Text] [Related]
15. The Remarkable Anti-Breast cancer Efficacy and Anti-Metastasis by Multifunctional Nanoparticles Co-Loading Squamocin, R848 and IR 780.
Wang X; Liu X; Guo Y; Gong T; Lu W; Han M; Guo Y; Wang X
Int J Nanomedicine; 2024; 19():4679-4699. PubMed ID: 38803997
[TBL] [Abstract] [Full Text] [Related]
16. Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway.
Liu M; Wu S; Wu H; Zhou Y; Zhang X; Zhu D; Jiang J
J Transl Med; 2024 May; 22(1):510. PubMed ID: 38802900
[TBL] [Abstract] [Full Text] [Related]
17. [An analysis of disease burden of occupational lung cancer in China from 1990 to 2019].
Ma HJ; Huang SX; Zeng N
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 May; 42(5):355-359. PubMed ID: 38802309
[No Abstract] [Full Text] [Related]
18. Imrecoxib: Advances in Pharmacology and Therapeutics.
Wang YH; Zhu LL; Li TL; Zhou Q
Drug Des Devel Ther; 2024; 18():1711-1725. PubMed ID: 38799798
[TBL] [Abstract] [Full Text] [Related]
19. Spatial interaction and functional status of CD68
Liu X; Zhang Z; Yuan J; Yu J; Chen D
Front Immunol; 2024; 15():1396719. PubMed ID: 38799432
[TBL] [Abstract] [Full Text] [Related]
20. Newly synthesized acridone derivatives targeting lung cancer: A toxicity and xenograft model study.
Bhusare N; Yadav T; Nandave M; Gadade A; Dighe V; Peters GJ; Kumar MS; Yergeri MC
Drug Dev Res; 2024 Jun; 85(4):e22212. PubMed ID: 38798193
[TBL] [Abstract] [Full Text] [Related]
[Next]
